Novartis MDx Focuses on Companion Dx as Key Strategic Direction | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Created three years ago, Novartis Molecular Diagnostics has set its focus on the companion diagnostics space, a market that remains relatively small, but one that the head of Novartis MDx called "a very significant piece of the strategic direction of the company."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.